GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Genmab AS GMAB · USD

Health Care · US listing · 🇺🇸 United States

Compare

55.80

+4.05%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Genmab AS and similar listings

Same market and sector, closest in size

Name Last closeMarket valueP/ENet marginYield Change
Genmab AS GMAB 55.80$34.26bn35.125.9%— +4.05%
Regencell Bioscience Holdings RGC 5.63$2.78bn—3.6%— +6.74%
Insulet PODD 149.81$10.77bn45.09.1%— +2.25%
Universal Health Services UHS 197.16$13.39bn8.88.6%0.41% +0.85%
Cooper Companies COO 63.93$12.79bn34.49.2%— +2.52%
BridgeBio Pharma BBIO 77.93$15.02bn—-145.3%— +4.90%
Moderna MRNA 269.00$105.09bn—-145.2%— +5.83%
West Pharmaceutical Services WST 413.09$30.03bn60.216.1%0.22% +3.32%
Summit Therapeutics SMMT 17.84$12.82bn—-11095.8%— +9.25%

Closes are in the currency each stock trades in. Blank figures mean we hold no company data for that listing yet.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.